CHARACTERIZATION AND REGULATION OF PROSTAGLANDIN E(2) RECEPTORS ON NORMAL AND MALIGNANT MURINE B-LYMPHOCYTES

被引:25
作者
BROWN, DM
PHIPPS, RP
机构
[1] UNIV ROCHESTER,SCH MED,CTR CANC,DEPT MICROBIOL & IMMUNOL,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED,CTR CANC,DEPT PEDIAT,ROCHESTER,NY 14642
关键词
D O I
10.1006/cimm.1995.1011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostaglandin E(2) (PGE(2)) is a pleiotropic lipid molecule synthesized by macrophages, follicular dendritic cells, and fibroblasts, inhabitants of the B cell microenvironment. It is a potent regulator of B lymphocyte functions including activation and immunoglobulin class switching. To understand the effects of PGE(2) on B lymphocyte function, the features of the putative PGE(2) receptor on cells of the B lineage must be delineated, This receptor has not yet been characterized on B lymphocytes, Murine B cell lymphomas were used as a model to evaluate B lineage PGE(2) receptors since they elevate intracellular cAMP in response to PGE(2). Scatchard analysis indicates that the PGE(2) receptor on both CH31 and CH12 exists in a single high-affinity state, with the CH12 B lymphoma possessing three times more receptors per cell compared to CH31. Interestingly, the PGE(2) receptor is subject to regulation as a 20-hr LPS treatment increased PGE(2) receptor number by two- to threefold on CH12 and CH31 B cell lymphomas, while dissociation constants remained similar. Finally, Scatchard analysis of normal murine splenic B lymphocytes demonstrates that they also possess high-affinity receptors for PGE(2). Treatment of normal B cells with IL-4 increased PGE(2) receptor levels fourfold from approximately 50 to 200 sites/cell while the affinity of the receptor slightly decreased. These results are the first to describe the number and affinity of PGE(2) receptors on cells of the B lineage. These findings also suggest that B lymphocyte-activating molecules such as LPS and IL-4 may enhance sensitivity to PGE(2) by upregulating the number of PGE(2) receptors on B cells, Moreover, these observations may be of importance in developing strategies to specifically control the spread of PGE(2)-sensitive B lymphomas. (C) 1995 Academic Press, Inc.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 42 条
  • [21] A NEW VIEW OF PROSTAGLANDIN-E REGULATION OF THE IMMUNE-RESPONSE
    PHIPPS, RP
    STEIN, SH
    ROPER, RL
    [J]. IMMUNOLOGY TODAY, 1991, 12 (10): : 349 - 352
  • [22] E-SERIES PROSTAGLANDINS ARE POTENT GROWTH-INHIBITORS FOR SOME B-LYMPHOMAS
    PHIPPS, RP
    LEE, D
    SCHAD, V
    WARNER, GL
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (06) : 995 - 1001
  • [23] QUILL H, 1989, J IMMUNOL, V142, P813
  • [24] RADDASSI K, 1991, J LIPID MEDIATOR, V4, P185
  • [25] RAE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P75
  • [26] REDUCED PROSTAGLANDIN-E2 (PGE2) RECEPTORS ON ATOPIC LYMPHOCYTE-T
    ROCKLIN, RE
    THISTLE, L
    [J]. CELLULAR IMMUNOLOGY, 1986, 99 (01) : 294 - 299
  • [27] PROSTAGLANDIN E(2) INHIBITS B-LYMPHOCYTE ACTIVATION BY A CAMP-DEPENDENT MECHANISM - PGE-INDUCIBLE REGULATORY PROTEINS
    ROPER, RL
    LUDLOW, JW
    PHIPPS, RP
    [J]. CELLULAR IMMUNOLOGY, 1994, 154 (02) : 296 - 308
  • [28] ROPER RL, 1990, J IMMUNOL, V145, P2644
  • [29] SCHAD VC, 1988, J IMMUNOL, V141, P79
  • [30] SCOTT DW, 1993, IMMUNOMETHODS, V2, P105